Biotechnology exchange traded funds (ETFs) are on the up-and-up this morning. Here are some stories on the topic that may interest you further:

The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.